Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
Neus Giménez, Rupal Tripathi, Ariadna Giró, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

A Review of Artificial Intelligence Applications in Hematology Management: Current Practices and Future Prospects
Yousra El Alaoui, Adel Elomri, Marwa Qaraqe, et al.
Journal of Medical Internet Research (2022) Vol. 24, Iss. 7, pp. e36490-e36490
Open Access | Times Cited: 33
Targeting metabolic reprogramming in chronic lymphocytic leukemia
Yu Nie, Xiaoya Yun, Ya Zhang, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Nikolaos Spyrou, et al.
Current Obesity Reports (2023) Vol. 13, Iss. 1, pp. 1-34
Open Access | Times Cited: 14
Targeting cholesterol homeostasis in hematopoietic malignancies
Andrea Brendolan, Vincenzo Russo
Blood (2021) Vol. 139, Iss. 2, pp. 165-176
Open Access | Times Cited: 28
Effect of Statins in the Watch and Wait Phase of Chronic Lymphocytic Leukemia
David Spaner
Cancer Medicine (2025) Vol. 14, Iss. 8
Open Access
Combination Therapies in Drug Repurposing: Personalized Approaches to Combatting Leukaemia and Multiple Myeloma
Bernice A. Monchusi, Pritam N. Dube, Mutsa M. Takundwa, et al.
Advances in experimental medicine and biology (2025)
Closed Access
Leveraging altered lipid metabolism in treating B cell malignancies
Jae Woong Lee, Arya Mani, Min‐Jeong Shin, et al.
Progress in Lipid Research (2024) Vol. 95, pp. 101288-101288
Open Access | Times Cited: 3
Optimization of diagnosis and treatment of hematological diseases via artificial intelligence
Shixuan Wang, Zoufang Huang, Jing Li, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
In Silico Modeling of Fabry Disease Pathophysiology for the Identification of Early Cellular Damage Biomarker Candidates
Javier Gervas‐Arruga, Miguel Ángel Barba-Romero, Julián Fernández-Martín, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10329-10329
Open Access | Times Cited: 2
The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis
Alana M. White, Giles Best, Anya K. Hotinski, et al.
Metabolites (2023) Vol. 13, Iss. 7, pp. 799-799
Open Access | Times Cited: 6
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
Juliana C. Santos, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5601-5601
Open Access | Times Cited: 8
Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors
Dennis Juarez, Roberta Buono, Shannon M. Matulis, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 12, pp. 2497-2509
Open Access | Times Cited: 4
A Multi-Objective Approach for Drug Repurposing in Preeclampsia
Eduardo Tejera, Yunierkis Pérez‐Castillo, Andrea Chamorro, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 777-777
Open Access | Times Cited: 10
Targeting lipid metabolism overcomes BTK inhibitor resistance in diffuse large B-cell lymphoma
Zhuojun Liu, Chenyue Wu, Zhaohua Yao, et al.
Medicine in Novel Technology and Devices (2024) Vol. 22, pp. 100295-100295
Open Access | Times Cited: 1
Prioritizing Molecular Biomarkers in Asthma and Respiratory Allergy Using Systems Biology
Lucía Cremades‐Jimeno, María Ángeles de Pedro, María López-Ramos, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 9
Proteomics and Drug Repurposing in CLL towards Precision Medicine
Dimitra Mavridou, Konstantina Psatha, Michalis Aivaliotis
Cancers (2021) Vol. 13, Iss. 14, pp. 3391-3391
Open Access | Times Cited: 8
An in silico approach to identify early damage biomarker candidates in metachromatic leukodystrophy
Jessica Gómez, Laura Artigas, Raquel Valls, et al.
Molecular Genetics and Metabolism Reports (2023) Vol. 35, pp. 100974-100974
Open Access | Times Cited: 2
Prospects for the use of statins in antiviral therapy
Р. Н. Мустафин
Clinical Microbiology and Antimicrobial Chemotherapy (2023) Vol. 25, Iss. 1, pp. 56-67
Open Access | Times Cited: 1
Machine Learning-Driven Biomarker Discovery for Skeletal Complications in Type 1 Gaucher Disease Patients
Jorge J. Cebolla, Pilar Giraldo, Jessica Gómez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8586-8586
Open Access
Pathway Gene Paralogues and Transcription Factors Differentially Associate with Contents of Picrosides in Tissues and Populations of a Medicinal Herb, Picrorhiza kurroa
Roma Pandey, Anjali Kharb, Ashish Sharma, et al.
Biochemical Genetics (2024)
Closed Access
Identification of Potential Muscle Biomarkers in McArdle Disease: Insights from Muscle Proteome Analysis
Inés García‐Consuegra, Sara Marcos Asensio, Rocío Garrido-Moraga, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4650-4650
Open Access | Times Cited: 1
Genome-wide identification and analysis of the evolution and expression pattern of the SBP gene family in two Chimonanthus species
Ge-Ge Jiang, Qianqian Wan, Wei Zou, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9107-9119
Closed Access
A Review of Artificial Intelligence Applications in Hematology Management: Current Practices and Future Prospects (Preprint)
Yousra El Alaoui, Adel Elomri, Marwa Qaraqe, et al.
(2022)
Open Access
Disputable questions of statins antitumor effects in hemoblastoses
Р. Н. Мустафин
Oncohematology (2022) Vol. 17, Iss. 3, pp. 108-113
Open Access
Page 1

Scroll to top